Serum pro-inflammatory (IL-1β and IL-2) cytokines are elevated mainly in early-stage (AD with mild cognitive impairment), in comparison to healthy controls and more advanced AD cases (King et al. 2018). Here, IL2 is linked to Alzheimer disease.